Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00532662Phase 4Unknown
Phase 4, randomised, double-blind trial of esketamine in postoperative pain, sponsored by Tehran University of Medical Sciences. Primary endpoint: Pain Score at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00532662.